• Biofrigas posted a loss after financial items of SEK 3.2 million in Q2 2026, narrowing from SEK 3.34 million a year earlier.
• Net sales were nil, unchanged year on year; earnings per share improved to SEK -0.02 from SEK -0.06.
• Equity ratio edged down 0.4 percentage points to 75.7%.
• Habo plant reached commercial operations, producing vehicle-grade gas with high methane content and low carbon dioxide.
• A rights issue raised about SEK 10.6 million before costs; management said focus remains on commercializing Habo phase 2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrigas Sweden AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 202608280245BITN____UKPR__SV_20260827-BIT-3233-0) on August 28, 2026, and is solely responsible for the information contained therein.